Lonza and Asimov Partner to Advance Lentiviral Vector Manufacturing for In Vivo Therapies

Collaboration connects Asimov’s genetic design and cell line technologies with Lonza’s process development, scale-up and GMP manufacturin...

October 05, 2026 | Monday | News
Daiichi Sankyo, AstraZeneca and Summit Partner to Evaluate Datroway and Ivonescimab in Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/NYSE: AZN) have entered into a clinical trial collaboration agreement with Summit Therapeutics Inc. (Na...

October 05, 2026 | Monday | News
Curaleaf and Jupiter Research Launch QMID Medical Cannabis Inhalation Device in Australia

Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in partnership with Jupiter Research LLC, announced that its Que Medical Inhalation Dev...

October 05, 2026 | Monday | News
Samfara Acquires Chr. Olesen Synthesis to Expand Pharmaceutical API Business

Samfara, a European life sciences investment firm, announced that it has completed the acquisition of Chr. Olesen Synthesis from Chr. Olesen and funds mana...

October 05, 2026 | Monday | News
Axogen Completes BioCircuit Acquisition to Expand Peripheral Nerve Repair Portfolio

Axogen, Inc. (“Axogen” or the “Company”) (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions ...

October 05, 2026 | Monday | News
Mironid Doses First Patients in Phase 1 Trial of LoAc® Therapy for ADPKD

Phase 1 study is evaluating the safety, tolerability and pharmacokinetics of Mironid’s lead LoAc® small molecule in healthy volunteers Dosing ...

October 02, 2026 | Friday | News
Ensera Launches Alliance Network to Streamline Drug-Device Combination Product Commercialisation

Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together l...

October 02, 2026 | Friday | News
Rakovina Therapeutics and Celvion Partner to Advance AI-Driven Precision Cancer Therapies

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0) (OTCMKTS: RKVTF) a biopharmaceutical company advancing innovative cancer therapies through AI-powered d...

October 02, 2026 | Friday | News
Roche Launches Newborn Screening Test for SMA, SCID and Sickle Cell Disease

This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), an...

October 01, 2026 | Thursday | News
Egle Therapeutics Reports Phase 1 Data for Treg-Selective EGL-003 in Autoimmune Disease

EGL-003, a selective IL-2 agonist, was well tolerated across all four dose cohorts. EGL-003 produced selective, dose-dependent Treg expansion without am...

October 01, 2026 | Thursday | News
Terumo Neuro to Acquire Arsenal Medical to Expand Liquid Embolic Portfolio

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., a privately held, clinical-stage biomaterials company developing Ne...

October 01, 2026 | Thursday | News
Verdiva Bio Presents VRB-103 Oral Amylin Data for Obesity Treatment

Verdiva Bio Limited (“Verdiva Bio” or “the Company”), a clinical-stage biotechnology company advancing the development of a portfol...

September 30, 2026 | Wednesday | News
Innovent Reports Phase 1 Data for IBI3003 Trispecific Antibody in Multiple Myeloma

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercializat...

September 30, 2026 | Wednesday | News
Kither Biotech Doses First Patients in KIT2014 COPD Clinical Trial

KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), non-CF bronch...

September 30, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close